Mission statement

Neopharm is a company specialised in the development and distribution of original, high quality therapeutic products made to improve the health and well-being of patients.


Neopharm was founded in 1996.

Until 2002 the company traded in medicinal products, substances and chemicals. on the domestic and international markets.

The company started its own manufacturing activities in 2003, launching its first product, Neopholic, on the market in the summer of the same year. The company has developed 32 products under its own registered trade mark and several new products are going to appear on the market during 2017.


Neopharm is one of the fastest growing companies on the Bulgarian pharmaceutical market.

Since its establishment Neopharm’s sales faster than the average pharmaceutical market growth rate in Bulgaria.

According to IMS data, during 2003 – 2013 the estimated average annual growth rate is 7.35%.

The average annual growth rate (AAGR) of Neopharm during 2003 – 2013 was 59.8%, and the composite annual growth rate (CAGR) was 47.11%.